| View |
|
DRP-12771
|
Acyclovir
|
Saphrivax-400
|
400 mg
|
Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
06 October 2022
|
06 October 2027
|
| View |
|
DRP-12772
|
Aciclovir
|
Saphrivax -800
|
800 mg
|
Tablet
|
Antiviral (Direct Acting Antiviral)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
06 October 2022
|
06 October 2027
|
| View |
|
DRP-12761
|
Clindamycin (As Hydrocholride)
|
Clindasaph 300
|
300 mg
|
Capsule
|
Antibacterial (Lincosamide)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
04 October 2022
|
04 October 2027
|
| View |
|
DRP-11945-01
|
Clobetasol Propionate
|
None
|
500 mcg/g (0.05% w/w)
|
Topical Ointment
|
Corticosteroid
|
KLM Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
14 October 2022
|
23 May 2027
|
| View |
|
DRP-11954-01
|
Fusidic Acid
|
None
|
20 mg/g (2% w/w)
|
Topical Cream
|
Antibacterial
|
KLM Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
14 October 2022
|
26 May 2027
|
| View |
|
DRP-8318-01
|
Docetaxel
|
Ocetax
|
20 mg/mL Concentrate Solution for IV Infusion
|
|
20 mg/mL Concentrate Solution for IV Infusion
|
Intas Pharmaceuticals Limited
|
India
|
Renewal
|
20 October 2024
|
17 October 2029
|
| View |
|
DRP-10835-02
|
Iron
|
Ferustab
|
105.6 mg (equivalent to 325 mg Ferrous Sulfate)
|
Sugar Coated Tablet
|
Hematinic/Antianemic
|
Centurion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
13 October 2022
|
02 December 2026
|
| View |
|
DRP-12836
|
Folic Acid
|
Folmaterna
|
5 mg
|
Capsule
|
-
|
Flamingo Pharmaceuticals Ltd.
|
India
|
PCPR Conversion
|
13 October 2022
|
25 October 2027
|
| View |
|
DRP-12832
|
Thiamazole
|
Methimax
|
5mg
|
Tablet
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
PCPR Conversion
|
13 October 2022
|
24 August 2025
|
| View |
|
DRP-6879-01
|
Escitalopram (as Oxalate)
|
ESLOPRAM 10
|
10 mg
|
Film-Coated Tablet
|
Antidepressant (Selective Serotonin Reuptake Inhibitor)
|
Hetero Labs Limited (Unit V)
|
India
|
Renewal
|
16 November 2023
|
03 November 2028
|
| View |
|
DRP-10725-01
|
Cetirizine Hydrochloride
|
None
|
10 mg
|
Film-Coated Tablet
|
Antihistamine (Piperazine Derivative)
|
Centurion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
23 March 2022
|
15 November 2026
|
| View |
|
DRP-1969-03
|
Amoxicillin (As Trihydrate)
|
Savermox
|
500 mg
|
Capsule
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
23 June 2021
|
23 February 2026
|
| View |
|
DRP-7128-05
|
Sitagliptin (as phosphate monohydrate)
|
None
|
100 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
17 October 2022
|
20 April 2026
|
| View |
|
DRP-7129-05
|
Sitagliptin (as phosphate monohydrate)
|
None
|
50 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
17 October 2022
|
20 April 2026
|
| View |
|
DRP-12857
|
Nebivolol hydrochloride
|
Nebicar
|
5 mg
|
Tablet
|
-
|
Micro Labs Limited
|
India
|
PCPR Conversion
|
17 October 2022
|
05 July 2025
|
| View |
|
DRP-12852
|
Pioglitazone (as hydrochloride) + Metformin hydrochloride
|
Prialta-Met
|
30 mg/500 mg
|
Sustained Release Tablet
|
Oral Hypoglycemic
|
Micro Labs Limited
|
India
|
Renewal
|
21 April 2024
|
27 June 2029
|
| View |
|
DRP-12853
|
Pioglitazone (as hydrochloride) + Metformin hydrochloride
|
Prialta-Met
|
15 mg/500 mg
|
Sustained Release Tablet
|
Oral Hypoglycemic
|
Micro Labs Limited
|
India
|
Renewal
|
05 May 2024
|
28 June 2029
|
| View |
|
DRP-12850
|
Tolvaptan
|
Samsca
|
15 mg
|
Tablet
|
-
|
Korea Otsuka Pharmaceutical Co., Ltd
|
Korea
|
PCPR Conversion
|
17 October 2022
|
23 April 2026
|
| View |
|
DRP-12858
|
Cilostazol
|
Pletaal SR
|
100 mg
|
Sustained Release Capsule
|
-
|
Korea Otsuka Pharmaceutical Co., Ltd.
|
Korea
|
PCPR Conversion
|
17 October 2022
|
16 October 2025
|
| View |
|
DRP-10623-01
|
Sitagliptin (as phosphate)
|
Phigliptin 100
|
100 mg
|
Tablet
|
Dipeptidyl peptidase 4 (DPP-4) Inhibitor
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
-
|
21 February 2022
|
28 October 2026
|